Valeo Pharma Inc. Stock Canadian Securities Exchange
Stocks
VPH
CA91915B1085
Pharmaceuticals
OTC Markets Traded|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.6600 CAD | -.--% |
|
+1.54% | -10.81% |
| Market Cap | 6.24M 4.41M 3.86M 3.56M 3.29M 421M 6.34M 42.53M 16.7M 207M 16.57M 16.2M 713M | P/E 2022 |
-2.09x | P/E 2023 | -0.45x |
|---|---|---|---|---|---|
| Enterprise Value | 64.5M 45.62M 39.9M 36.8M 33.99M 4.35B 65.58M 440M 173M 2.14B 171M 168M 7.37B | EV / Sales 2022 |
3.37x | EV / Sales 2023 | 1.35x |
| Free-Float |
52.66% | Yield 2022 * |
-
| Yield 2023 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Tougas
DFI | Director of Finance/CFO | - | 2023-11-19 |
Nelly Komari
CTO | Chief Tech/Sci/R&D Officer | - | 2021-05-31 |
Frédéric Dumais
IRC | Investor Relations Contact | - | 2019-05-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Steven Saviuk
CHM | Chairman | 67 | 2024-08-05 |
Richard MacKay
CHM | Chairman | 91 | 2018-07-24 |
Marc Léger
BRD | Director/Board Member | 67 | 2022-04-26 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | +1.54% | - | - | 98 | |
| -2.33% | -2.09% | +50.33% | +162.29% | 1,060B | |
| -0.82% | -2.30% | +62.97% | +61.11% | 619B | |
| -0.73% | -4.98% | +27.22% | +84.46% | 438B | |
| +0.33% | -1.17% | +27.98% | +26.90% | 333B | |
| -0.02% | -2.85% | +25.27% | +44.88% | 282B | |
| -3.89% | -11.22% | +20.78% | +26.07% | 267B | |
| +0.66% | -1.42% | -29.26% | -39.30% | 218B | |
| -0.06% | -2.88% | +20.98% | +61.70% | 196B | |
| -3.72% | -1.10% | +13.35% | +71.53% | 161B | |
| Average | -0.80% | -3.25% | +24.40% | +55.51% | 397.1B | |
| Weighted average by Cap. | -0.56% | -2.96% | +35.28% | +81.27% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 27.74M 19.62M 17.16M 15.83M 14.62M 1.87B 28.21M 189M 74.28M 922M 73.68M 72.07M 3.17B | 53.91M 38.13M 33.35M 30.76M 28.41M 3.64B 54.82M 368M 144M 1.79B 143M 140M 6.16B |
| Net income | -25.75M -18.21M -15.93M -14.69M -13.57M -1.74B -26.18M -176M -68.93M -856M -68.37M -66.88M -2.94B | -27.81M -19.67M -17.2M -15.87M -14.66M -1.88B -28.28M -190M -74.45M -924M -73.84M -72.24M -3.18B |
| Net Debt | 38.94M 27.54M 24.09M 22.22M 20.52M 2.63B 39.59M 265M 104M 1.29B 103M 101M 4.45B | 58.26M 41.2M 36.04M 33.24M 30.7M 3.93B 59.24M 397M 156M 1.94B 155M 151M 6.66B |
Employees
-
Sector
Pharmaceuticals
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- VPHIF Stock
- VPH Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
